Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cristina García-Yubero"'
Autor:
Ana Esteban-Vazquez, Martina Steiner, Elisabet Castañeda, Cristina Andreu-Vazquez, Israel J. Thiussard, Angela Somodevilla, Moisés Gracia-Martínez, Rosa Sánchez-Diaz, Cristina García-Yubero, Maria Beatriz Paredes-Romero, Santiago Munoz-Fernández
Publikováno v:
Vaccines, Vol 11, Iss 10, p 1610 (2023)
Background. The risk of herpes zoster reactivation is increased in immunocompromised patients, especially in those with immune-mediated inflammatory diseases (IMIDs) on Janus kinase inhibitor (JAKi) treatment. The recombinant subunit herpes zoster va
Externí odkaz:
https://doaj.org/article/6f51cbb61a8445348f65f9a4224d22b0
Autor:
Ángeles, Castro, Pilar, Díaz, Pere, Domingo, Cristina, García-Yubero, Juan E, Losa-García, Antonio, Castro, Neus, Vidal-Vilar, Susana, Aceituno
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(6)
To assess the use of resources and the costs associated with following up patients infected with the human immunodeficiency virus after discontinuation of an antiretroviral treatment and initiation of a new one due to a lack of effectiveness or unacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00a783c8950ef9c0f31e48934278f667
https://pubmed.ncbi.nlm.nih.gov/36520571
https://pubmed.ncbi.nlm.nih.gov/36520571
Autor:
Marta, Ruiz-Algueró, Belén, Alejos, Cristina, García Yubero, Melchor, Riera Jaume, José, Antonio Iribarren, Víctor, Asensi, Francisco, Pasquau, Carlos E, Galera, Mario, Pascual-Carrasco, Adolfo, Muñoz, Inmaculada, Jarrín, Inés, Suárez-García, Juan A, Pineda
Publikováno v:
AIDS research and human retroviruses. 38(6)
The present study sought to describe the use of generic drugs and single-tablet regimen (STR) de-simplification for the treatment of human immunodeficiency virus (HIV) infection among 41 hospitals from the cohort of the Spanish HIV/AIDS Research Netw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0c488836635366fc7cf357eb345484f
https://pubmed.ncbi.nlm.nih.gov/35357907
https://pubmed.ncbi.nlm.nih.gov/35357907
Autor:
Inés Suárez-García, Marta Ruiz-Algueró, Belén Alejos, Cristina García-Yubero, Mª José Belza, Ramón Espacio, Juanse Hernández, Josefa Muñoz Sánchez, Ainhoa Garaialde, María del Mar Alonso Socas, Antonia Alcaraz, Beatriz Pierola Ruiz de Galarreta, Onofre Juan Martínez Madrid, Isabel Gutiérrez Cuéllar, Cristina Gómez-Ayerbe, Julián Olalla, Inma Jarrín
Objectives: The aims of this study were to describe patients' experiences after single-tablet regimen (STR) desimplification and its impact on self-reported treatment adherence and quality of life. Methods: We performed a survey among all patients fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c912ee7369f3b04fb84e6f324328e5e0
https://hdl.handle.net/11268/11455
https://hdl.handle.net/11268/11455
Autor:
Martina Steiner, Ana Victoria Esteban, Cristina García-Yubero, Santiago Muñoz-Fernández, Alejandro Gómez Gómez, Noemí Manceñido, Teresa Navío, Maria Angeles Matías, Tatiana Cobo-Ibáñez, Laura Cebrian, Israel Thuissard, Liz Romero, Cristina Andreu, Mar Esteban, Fernando Sánchez, Concepción Esteban, María Rosario Arribas, R. Pajares, Alicia Martínez
Publikováno v:
Journal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases. 28(2)
OBJECTIVES: The aim of this study was to examine the incidence of coronavirus disease 2019 (COVID-19) among patients with immunomediated inflammatory diseases (IMIDs) treated with biologic or targeted synthetic disease-modifying antirheumatic drugs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed88a57852c48e57a3736974cd027f24
https://pubmed.ncbi.nlm.nih.gov/33657593
https://pubmed.ncbi.nlm.nih.gov/33657593
Autor:
Manuel Vélez-Díaz-Pallarés, Javier Sánchez-Rubio, Cristina García Yubero, Patricia Sanmartin Fenollera, María Fernández-Pacheco García-Valdecasas, Carmen Rodríguez González
Publikováno v:
Sexually Transmitted Infections
Antiretroviral prophylaxis started within 72 hours of a possible exposure is a feasible and cost-effective measure to prevent HIV infection.1 In Spain, post-exposure prophylaxis (PEP) is provided free-of-charge via a hospital-based HIV specialist. As
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7bdb13459ad8b6076b8fe40c92c61fb
Autor:
Tatiana Cobo-Ibáñez, Gemma Mora Ortega, Carlos Sánchez-Piedra, Gonzalo Serralta-San Martín, Israel J. Thuissard-Vasallo, Vanesa Lores Gutiérrez, Llanos Soler Rangel, Cristina García Yubero, Ana Esteban-Vázquez, Elena López-Aspiroz, Cristina Andreu Vázquez, Inmaculada Toboso, Blanca María Martínez Alonso de Armiño, Rocío Alejandra Olivares Alviso, Rocío Calderón Nieto, Cecilia Yañez, Marlín Alejandra Zakhour González, Tatiana Sainz Sánchez, Silvia Arroyo de la Torre, Nazaret Del Amo Del Arco, Jorge Francisco Gómez-Cerezo, Teresa Ramírez Prieto, Alicia Martínez Hernández, Santiago Muñoz-Fernández
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Post-COVID-19 interstitial lung disease (ILD) is a new entity that frequently causes pulmonary fibrosis and can become chronic. We performed a single-center parallel-group open-label pilot randomized clinical trial to investigate the efficac
Externí odkaz:
https://doaj.org/article/0a00cfe00ed646dbb66d9354f4de6224